%0
Generic
%T
High-Risk Fludarabine-Pretreated B-Cell Chronic Lymphocytic Leukemia's High Response Rate Following Sequential DHAP and Alemtuzumab Administration Though in Absence of Molecular Remission
%A Majolino, Ignazio
%A Ladetto, Marco
%A Locasciulli, Anna
%A Drandi, Daniela
%A Benedetti, Fabio
%A Gallamini, Andrea
%A Chisesi, Teodoro
%A De Blasio, Angelo
%A Boccadoro, Mario
%A Tarella, Corrado
%I Springer Science and Business Media LLC
%@ 1357-0560
%K Cancer Research
%K Oncology
%K Hematology
%K General Medicine
%D 2006
%C Springer Science and Business Media LLC
%U http://slubdd.de/katalog?TN_libero_mab2